POLIVY (polatuzumab vedotin)
Australian Public Assessment Report
Device/Product Name
POLIVY
Active ingredients
Polatuzumab vedotin
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-05903-1-6
Submission Type
Extension of indications
Decision
Approved